Watch Ticker

Emergent Biosolutions, Inc.

Go to Emergent Biosolutions, Inc. Website

$6.01

0.06 (1.01%)

Live

Previous Close

$5.95

Day Range

$5.87 - $6.1

Previous Day Range

$5.615 - $6.04

Market Cap

$305.6 million USD

Day Vol.

414206

Previous Day Vol.

746780

Currency

USD

Primary Exchange

New York Stock Exchange

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal S...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Globe Newswire - Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Emergent BioSolutions has completed the sale of its Baltimore-Bayview drug substance manufacturing facility to Syngene International for approximately $36.5 million. The deal enables Emergent to streamline operations while maintaining flexibility for future product demand.

Related tickers: EBS.

Read Full Article

N/A - Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

Emergent BioSolutions and Rocketvax have announced a strategic partnership, where Emergent will invest in Rocketvax and lead the U.S. manufacturing and commercialization of four of Rocketvax's pipeline candidates for infectious diseases, cancer, and autoimmune disorders.

Related tickers: EBS.

Read Full Article

Trending Tickers

Please sign in to view